ClinicalTrials.Veeva

Menu

Effectiveness of Hyaluronic Acid Gel in the Prevention of Intrauterine Adhesions After Second Trimester Abortion

I

Istanbul University

Status and phase

Unknown
Phase 4

Conditions

Placenta Retained
Uterine Diseases

Treatments

Device: intrauterine self-cross-linked hyaluronic acid gel

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This prospective, randomized, controlled study evaluates the efficacy of self-crosslinked hyaluronic acid gel to prevent the development of de-novo intrauterine adhesions following curettage for retained product after second trimester abortion. One group of participants will underwent curettage plus intrauterine application of self-crosslinked hyaluronic acid gel while the other group will underwent curettage alone (control group).

Full description

Intrauterine adhesions are the major long-term complication of curettage for retained products of conception. The risk of adhesion is higher after second trimester abortion. This complication may result in infertility, recurrent miscarriages and irregular periods with dysmenorrhea and pelvic pain.

They have been reported that the intrauterine application of auto-crosslinked hyaluronic acid gel following hysteroscopic adhesiolysis or hysteroscopic surgery significantly reduces the formation of post-operative intrauterine adhesions.

The aim of this prospective, randomized, controlled study is to evaluate the efficacy of self-crosslinked hyaluronic acid gel in the reduction of development of de-novo post-curettage adhesions at 2 months follow-up.

Enrollment

60 estimated patients

Sex

Female

Ages

18 to 39 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subject has curettage for retained product after second trimester abortion

Exclusion criteria

  • History of curettage or other intrauterine surgery
  • History of post-abortion complication or infection

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Group 1
Active Comparator group
Description:
The patients who are having curettage for retained product after second trimester abortion will also receive an intervention of intrauterine self-cross-linked hyaluronic acid gel after the procedure
Treatment:
Device: intrauterine self-cross-linked hyaluronic acid gel
Group 2
No Intervention group
Description:
The patients who are having curettage for retained product after second trimester abortion will receive no intervention

Trial contacts and locations

0

Loading...

Central trial contact

Gamze Yilmaz, M.D.; Sultan Can, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems